Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin’s lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. 23. April 2019 12. Mai 2012 Share EmailTwitterFacebookGoogle +PinterestTumblrLinkedinVkontakte